CALCA and migraine disorder: The discovery of calcitonin gene-related peptide (CGRP), a neuropeptide with potent vasodilatory and neuromodulatory activity, and its role in migraine pathogenesis led to the development of several breakthrough therapeutics (Edvinsson et al., 2018).